Sign In
Buy SAN
$12.16
-0.250 (-2.01%)
At Close: Jun 03, 2026
Banco Santander, S.A. (NYSE:SAN) Receives Consensus Recommendation of “Hold” from Analysts
01:12am, Tuesday, 23'rd Dec 2025
Banco Santander, S.A. (NYSE: SAN - Get Free Report) has earned an average rating of "Hold" from the six research firms that are covering the firm, Marketbeat.com reports. One equities research analyst
Santander US Partners with Villanova University Athletics to Advance Opportunities for Student-Athletes
10:11am, Monday, 22'nd Dec 2025
BOSTON & VILLANOVA, Pa.--(BUSINESS WIRE)--Today, Santander US announced a multi-year partnership with Villanova University Athletics naming Santander the Official Retail Bank Partner of Villanova Athl
Our Top 10 High-Growth Dividend Stocks - December 2025
08:00am, Saturday, 20'th Dec 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat
Polish financial regulator gives green light for Erste's takeover of Santander
12:35pm, Wednesday, 17'th Dec 2025
The Polish financial regulator (KNF) has given a green light to Erste Group Bank AG's purchase of a controlling stake in Santander Bank Polska , it said in a statement on Wednesday.
Sanofi (SAN:CA) Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments Transcript
09:59pm, Tuesday, 16'th Dec 2025
Sanofi (SAN:CA) Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments Transcript
Santander agrees to $26 million settlement in France tax fraud case
01:31pm, Friday, 05'th Dec 2025
Spanish bank Santander has agreed to settle a tax fraud case opened in France in 2011 on with a payment of 22.5 million euros ($26.18 million), the Paris prosecutor said on Friday in a statement.
Press Release: Sanofi completes acquisition of Vicebio
05:00am, Thursday, 04'th Dec 2025
Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”).
Sanofi (SAN:CA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
07:23pm, Wednesday, 03'rd Dec 2025
Sanofi (SAN:CA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Sanofi (SAN:CA) Presents at Evercore 8th Annual Healthcare Conference Transcript
07:03am, Wednesday, 03'rd Dec 2025
Sanofi (SAN:CA) Presents at Evercore 8th Annual Healthcare Conference Transcript
Italy's doValue renews new bad loan management contract with Santander
02:45am, Wednesday, 03'rd Dec 2025
Italian debt recovery firm doValue Group said on Wednesday it had signed a contract with Spain's Banco Santander to manage new flows of impaired loans starting in January, replacing an agreement that
Santander to Sell Stake in Polish Subsidiary for Around $473 Million After Erste Group Deal
02:08am, Tuesday, 02'nd Dec 2025
The bank said it completed the placement of 3.58 million ordinary shares, representing around 3.5% of Santander Bank Polska's share capital.
Santander to sell 3.5% stake in its Polish unit for around $480 mln, bookrunner says
12:56pm, Monday, 01'st Dec 2025
Spain's Santander plans to sell an around 3.5% stake in its Polish subsidiary Santander Polska through an accelerated bookbuild for around $480 million, one of the bookrunners said on Monday.
Choreo LLC Purchases 20,530 Shares of Banco Santander, S.A. $SAN
05:42am, Monday, 01'st Dec 2025
Choreo LLC raised its position in Banco Santander, S.A. (NYSE: SAN) by 20.4% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi
Larry Summers resigns from Santander's advisory board, spokesperson says
03:41pm, Wednesday, 19'th Nov 2025
Former U.S. Treasury Secretary Larry Summers has resigned from Santander's international advisory board he currently chaired, a Santander spokesperson said on Wednesday.
Santander's Exposure to First Brands Founder Patrick James Reaches $300 Million
01:31pm, Wednesday, 19'th Nov 2025
Santander's exposure to companies owned by First Brands Group founder Patrick James has reportedly grown to $300 million. The increase was caused by James defaulting on a loan he took out to buy a Fre
